Cooper Investors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.97M Sell
27,046
-19,506
-42% -$5.4M 2.74% 15
2026
Q1
$13.7M Sell
46,552
-4,201
-8% -$1.25M 5.6% 3
2025
Q4
$13.9M Sell
50,753
-3,180
-6% -$864K 4.61% 6
2025
Q3
$14.6M Sell
53,933
-51,872
-49% -$14.1M 3.98% 7
2025
Q2
$29.2M Sell
105,805
-21,508
-17% -$5.85M 5.31% 3
2025
Q1
$33.8M Sell
127,313
-6,596
-5% -$1.63M 5.49% 3
2024
Q4
$31.1M Sell
133,909
-27,572
-17% -$6.34M 4.9% 5
2024
Q3
$35.6M Buy
161,481
+4,647
+3% +$962K 5.3% 4
2024
Q2
$30.8M Sell
156,834
-144,236
-48% -$29.8M 4.69% 6
2024
Q1
$64.8M Buy
301,070
+227,469
+309% +$47.8M 3.74% 13
2023
Q4
$15.5M Buy
73,601
+60,329
+455% +$12.9M 0.93% 26
2023
Q3
$2.46M Buy
+13,272
New +$2.64M 0.2% 31
2023
Q1
$2.32M Buy
12,136
+2,879
+31% +$521K 0.2% 30
2022
Q4
$1.56M Buy
9,257
+570
+7% +$99.1K 0.15% 34
2022
Q3
$1.54M Buy
8,687
+3,616
+71% +$715K 0.15% 32
2022
Q2
$1.04M Hold
5,071
0.09% 29
2022
Q1
$1.21M Sell
5,071
-153
-3% -$35.9K 0.08% 29
2021
Q4
$1.19M Sell
5,224
-190,915
-97% -$42M 0.08% 34
2021
Q3
$37.9M Buy
196,139
+42,779
+28% +$8.67M 2.51% 18
2021
Q2
$32.6M Hold
153,360
2.14% 22
2021
Q1
$31.3M Sell
153,360
-96,651
-39% -$19M 2.33% 20
2020
Q4
$45.5M Buy
250,011
+8,539
+4% +$1.45M 3.63% 13
2020
Q3
$40.4M Buy
241,472
+42,040
+21% +$7.08M 3.77% 12
2020
Q2
$32.4M Buy
199,432
+25,714
+15% +$4.61M 3.37% 11
2020
Q1
$30M Sell
173,718
-26,130
-13% -$5.2M 3.77% 11
2019
Q4
$40.1M Buy
199,848
+1,192
+0.6% +$245K 4.22% 10
2019
Q3
$42M Buy
198,656
+906
+0.5% +$189K 4.74% 10
2019
Q2
$38.4M Buy
197,750
+486
+0.2% +$89.6K 4.45% 10
2019
Q1
$32.5M Buy
197,264
+989
+0.5% +$175K 3.97% 11
2018
Q4
$36.9M Sell
196,275
-35,606
-15% -$6.58M 5.1% 10
2018
Q3
$39.5M Buy
231,881
+2,118
+0.9% +$357K 4.69% 9
2018
Q2
$37.7M Buy
229,763
+1,755
+0.8% +$287K 4.59% 9
2018
Q1
$36.9M Sell
228,008
-11,076
-5% -$1.76M 4.38% 9
2017
Q4
$34.9M Buy
239,084
+30,689
+15% +$4.37M 4.34% 10
2017
Q3
$28.3M Buy
208,395
+17,186
+9% +$2.17M 3.97% 11
2017
Q2
$23.9M Buy
191,209
+7,127
+4% +$852K 3.64% 13
2017
Q1
$21.9M Buy
184,082
+3,680
+2% +$443K 3.49% 11
2016
Q4
$20.8M Buy
180,402
+3,017
+2% +$336K 3.71% 11
2016
Q3
$18.5M Buy
177,385
+1,184
+0.7% +$124K 3.64% 13
2016
Q2
$17.2M Buy
+176,201
New +$16.7M 3.6% 12

Other funds holding CME

Cooper Investors's CME Position: Q2 2026 in Review

Cooper Investors reduced its CME Group (CME) stake by 42% in Q2 2026, selling an estimated $5.4M and leaving 27,046 shares worth $5.97M. The position accounts for 2.74% of the portfolio, ranked #15.

Cooper Investors first reported a position in CME in Q2 2016 and has held it in 40 quarters since. The position peaked at $64.8M in Q1 2024. 222 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Cooper Investors held 27,046 shares of CME Group worth $5.97M as of Q2 2026.
  • Cooper Investors sold 19,506 CME Group shares in Q2 2026, an estimated $5.4M.
  • CME Group made up 2.74% of Cooper Investors's portfolio in Q2 2026, its #15 holding.
  • Cooper Investors first reported a position in CME Group in Q2 2016 and has held it in 40 quarters since.
  • Cooper Investors's CME Group position peaked at $64.8M in Q1 2024.
  • 222 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Cooper Investors's 13F filing for Q2 2026, filed 7 Jul 2026.